FGFR3 and Leigh syndrome: Mutations in the telomerase reverse transcriptase (TERT) promoter and the fibroblast growth factor receptor 3 (FGFR3) gene are sometimes seen in LS and have been proposed as novel biomarkers of urothelial cancer (UC), which is the third most common cancer type in certain subsets of LS families [116,117].